{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:54:12Z","timestamp":1760982852867},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.bone.2008.12.016","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T09:18:29Z","timestamp":1230715109000},"page":"666-670","source":"Crossref","is-referenced-by-count":9,"title":["Critical issues of PTH assays in CKD"],"prefix":"10.1016","volume":"44","author":[{"given":"Hirotaka","family":"Komaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2008.12.016_bib1","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1021\/bi00619a019","article-title":"Complete amino acid sequence of human parathyroid hormone","volume":"17","author":"Keutman","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.bone.2008.12.016_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/endo-93-6-1349","article-title":"Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity","volume":"93","author":"Tregear","year":"1973","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2008.12.016_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bone.2008.12.016_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/endo.142.2.7955","article-title":"Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells","volume":"142","author":"Divieti","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2008.12.016_bib5","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/en.2004-1262","article-title":"Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity","volume":"146","author":"Divieti","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2008.12.016_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI110052","article-title":"Effects of hepatectomy, nephrectomy, and nephrectomy\/uremia on the metabolism of parathyroid hormone in the rat","volume":"67","author":"Segre","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2008.12.016_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI110053","article-title":"Metabolism of parathyroid hormone by isolated rat Kupffer's cells and hepatocytes","volume":"67","author":"Segre","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2008.12.016_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.mnh.0000172718.49476.64","article-title":"Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology","volume":"14","author":"D'Amour","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"Suppl 102","key":"10.1016\/j.bone.2008.12.016_bib9","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.ki.5001599","article-title":"Circulating PTH molecular forms: what we know and what we don't","volume":"70","author":"D'Amour","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2008.12.016_bib11","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"Suppl 102","key":"10.1016\/j.bone.2008.12.016_bib12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ki.5001594","article-title":"Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease","volume":"70","author":"Fukagawa","year":"2006","journal-title":"Kidney Int."},{"issue":"Suppl 3","key":"10.1016\/j.bone.2008.12.016_bib13","first-page":"iii2","article-title":"Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention","volume":"1","author":"Goto","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/j.bone.2008.12.016_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor-23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ndt\/gfh827","article-title":"With or without the kidney: the role of FGF23 in CKD","volume":"20","author":"Fukagawa","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2008.12.016_bib17","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2008.12.016_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1744-9987.2007.00540.x","article-title":"Effects of serum levels of calcium, phosphorous, and intact PTH on survival in chronic hemodialysis patients in Japan","volume":"12","author":"Nakai","year":"2008","journal-title":"Ther. Apher. Dial."},{"issue":"Suppl 3","key":"10.1016\/j.bone.2008.12.016_bib20","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib21","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.12.016_bib22","first-page":"21","article-title":"Evolution of the parathyroid hormone (PTH) assay-importance of circulating PTH immunoheterogeneity and of its regulation","volume":"51","author":"Gao","year":"2005","journal-title":"Clin. Lab."},{"key":"10.1016\/j.bone.2008.12.016_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF03346391","article-title":"Lessons from a second- and third-generation parathyroid hormone assays in renal failure patients","volume":"31","author":"D'Amour","year":"2008","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bone.2008.12.016_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/jcem-28-7-1037","article-title":"Immunochemical heterogeneity of parathyroid hormone in plasma","volume":"28","author":"Berson","year":"1968","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.12.016_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2008.12.016_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinchem\/46.5.697","article-title":"Influence of glomerular filtration rate on intact parathyroid hormone levels in renal failure patients: role of non-(1-84) PTH detected by intact PTH assays","volume":"46","author":"Brossard","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2008.12.016_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2008.12.016_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/en.2002-221026","article-title":"Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure","volume":"144","author":"Langub","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2008.12.016_bib29","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.12.016_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone (1-84): implication for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bone.2008.12.016_bib31","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1053\/ajkd.2001.27436","article-title":"Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients","volume":"38","author":"Nakanishi","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1373\/clinchem.2003.026831","article-title":"Technical and clinical characterization of the Bio-PTH(1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone","volume":"50","author":"Inaba","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2008.12.016_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Intermethod variability in PTH measurement: Implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.ajkd.2008.01.017","article-title":"Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study","volume":"51","author":"Joly","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/jcp.2004.022186","article-title":"Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice","volume":"58","author":"Twomey","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bone.2008.12.016_bib36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.ki.5002363","article-title":"Stability of intact parathyroid hormone in samples from hemodialysis patients","volume":"72","author":"Cavalier","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in endstage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminium: the role of \u2018suppressed\u2019 parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib39","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminium toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib40","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","article-title":"Improved assessment of bone turnover by the PTH-(1-84) large C-PTH fragments ratio in ESRD patients","volume":"60","author":"Monier-Faugere","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","article-title":"PTH 1-84 and PTH \u201c7-84\u201d in the noninvasive diagnosis of renal bone disease","volume":"40","author":"Coen","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1523-1755.2005.00513.x","article-title":"Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry","volume":"68","author":"Lehmann","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","author":"Guideline Working Group, Japanese Society for Dialysis Therapy","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.bone.2008.12.016_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (K\/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib45","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/ndt\/gfm849","article-title":"Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study","volume":"23","author":"Melamed","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2008.12.016_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/jc.2005-1628","article-title":"Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments\/PTH(1-84) ratios derived from three generations of PTH assays","volume":"91","author":"D'Amour","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.12.016_bib47","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jc.2005-0243","article-title":"Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells","volume":"90","author":"Kawata","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.12.016_bib48","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfh038","article-title":"Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism","volume":"19","author":"Kazama","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2008.12.016_bib49","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1523-1755.2005.00517.x","article-title":"First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl","volume":"68","author":"Martin","year":"2005","journal-title":"Kidney Int."},{"issue":"4 Suppl 1","key":"10.1016\/j.bone.2008.12.016_bib50","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1053\/ajkd.2001.27432","article-title":"More than 1000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism","volume":"38","author":"Tominaga","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib51","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1067\/msy.2000.110431","article-title":"Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism\u2014a consecutive series of 80 patients","volume":"128","author":"Lokey","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.bone.2008.12.016_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0039-6060(03)00387-8","article-title":"Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism","volume":"135","author":"Yamashita","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.bone.2008.12.016_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00268-004-7489-y","article-title":"Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism","volume":"29","author":"Yamashita","year":"2005","journal-title":"World J. Surg."},{"key":"10.1016\/j.bone.2008.12.016_bib54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00268-006-0601-8","article-title":"QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism","volume":"31","author":"Matsuoka","year":"2007","journal-title":"World J. Surg."},{"key":"10.1016\/j.bone.2008.12.016_bib55","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1373\/clinchem.2003.021592","article-title":"Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism","volume":"49","author":"D'Amour","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2008.12.016_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.2005.02286.x","article-title":"Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery","volume":"62","author":"R\u00e4kel","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2008.12.016_bib57","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2008.12.016_bib58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2215\/CJN.01391005","article-title":"Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia","volume":"1","author":"Arakawa","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2008.12.016_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP64069","article-title":"Normalization of reversed bio-intact-PTH(1-84)\/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism","volume":"64","author":"Tanaka","year":"2005","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bone.2008.12.016_bib60","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/ndt\/gfm891","article-title":"Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH\/intact PTH ratio in a haemodialysis patient","volume":"23","author":"Komaba","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl 3","key":"10.1016\/j.bone.2008.12.016_bib61","first-page":"iii54","article-title":"Reversed whole PTH\/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review","volume":"1","author":"Komaba","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/j.bone.2008.12.016_bib62","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5414\/CNP69310","article-title":"The reversed ratio of 1-84 PTH (whole PTH)\/intact PTH in a patient on hemodialysis associated with primary hyperparathyroidism","volume":"69","author":"Mizumura","year":"2008","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bone.2008.12.016_bib63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2005.060962","article-title":"Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism","volume":"52","author":"Boudou","year":"2006","journal-title":"Clin. Chem."},{"issue":"Suppl 3","key":"10.1016\/j.bone.2008.12.016_bib64","first-page":"iii59","article-title":"The whole-PTH\/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism","volume":"1","author":"Tanaka","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/j.bone.2008.12.016_bib65","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1053\/ajkd.2001.27426","article-title":"Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases","volume":"38","author":"Fukagawa","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib66","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib67","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib68","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2008.12.016_bib69","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/ndt\/gfm455","article-title":"The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure","volume":"22","author":"Yano","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2008.12.016_bib70","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2008.12.016_bib71","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2008.12.016_bib72","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2008.12.016_bib73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2008.12.016_bib74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208009794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208009794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T03:49:30Z","timestamp":1632887370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328208009794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S8756328208009794"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2008.12.016","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}